DrugPatentWatch Database Preview
CLINICAL TRIALS PROFILE FOR DUREZOL
» See Plans and Pricing
All Clinical Trials for Durezol
| Trial ID | Title | Status | Sponsor | Phase | Start Date | Summary |
|---|---|---|---|---|---|---|
| NCT01124045 | Difluprednate Pediatric Study for the Treatment of Inflammation Post-Cataract Surgery | Completed | Alcon Research | Phase 3 | 2010-08-01 | The primary objective of this study was to compare the safety and efficacy of Durezol™ compared to Pred Forte™ for the treatment of inflammation following cataract surgery in a pediatric population 0 to 3 years of age. |
| NCT01201798 | Safety and Efficacy of Difluprednate 0.05% for the Treatment of Anterior Uveitis | Completed | Alcon Research | Phase 3 | 2010-10-01 | The purpose of this study was to demonstrate that difluprednate 0.05% (Durezol) dosed 4 times daily is noninferior to prednisolone 1% (Pred Forte) dosed 8 times daily for the treatment of endogenous anterior uveitis. |
| NCT01244334 | Study of Difluprednate vs. Prednisolone Acetate on Visual Acuity, and Corneal Edema Following Cataract Surgery. | Completed | Alcon Research | Phase 4 | 2009-03-01 | The purpose of this clinical research study is to investigate the efficacy of predosing patients undergoing cataract surgery with the potent corticosteroid difluprednate ophthalmic emulsion 0.05% compared to prednisolone acetate 1% on corneal edema (swelling), and retinal thickness. |
| NCT01244334 | Study of Difluprednate vs. Prednisolone Acetate on Visual Acuity, and Corneal Edema Following Cataract Surgery. | Completed | Parsons Medical Communications | Phase 4 | 2009-03-01 | The purpose of this clinical research study is to investigate the efficacy of predosing patients undergoing cataract surgery with the potent corticosteroid difluprednate ophthalmic emulsion 0.05% compared to prednisolone acetate 1% on corneal edema (swelling), and retinal thickness. |
| NCT01244334 | Study of Difluprednate vs. Prednisolone Acetate on Visual Acuity, and Corneal Edema Following Cataract Surgery. | Completed | Sirion Therapeutics, Inc. | Phase 4 | 2009-03-01 | The purpose of this clinical research study is to investigate the efficacy of predosing patients undergoing cataract surgery with the potent corticosteroid difluprednate ophthalmic emulsion 0.05% compared to prednisolone acetate 1% on corneal edema (swelling), and retinal thickness. |
| NCT01244334 | Study of Difluprednate vs. Prednisolone Acetate on Visual Acuity, and Corneal Edema Following Cataract Surgery. | Completed | Edward J. Holland | Phase 4 | 2009-03-01 | The purpose of this clinical research study is to investigate the efficacy of predosing patients undergoing cataract surgery with the potent corticosteroid difluprednate ophthalmic emulsion 0.05% compared to prednisolone acetate 1% on corneal edema (swelling), and retinal thickness. |
| NCT01276223 | Evaluation of Anti-Inflammatory Treatment in Dry Eye Patients | Completed | Alcon Research | Phase 2 | 2011-02-01 | The purpose of this study was to determine if difluprednate ophthalmic emulsion is effective in reducing the ocular symptoms of dry eye disease, as measured by a global Visual Analog Scale (VAS) discomfort score. |
| >Trial ID | >Title | >Status | >Sponsor | >Phase | >Start Date | >Summary |
Clinical Trial Conditions for Durezol
Condition Name
Clinical Trial Locations for Durezol
Trials by Country
Clinical Trial Progress for Durezol
Clinical Trial Phase
Clinical Trial Sponsors for Durezol
Sponsor Name
